Bioink for this model included patient-derived glioblastoma cells, astrocytes and microglia, allowing assessment of the proliferation of these cells by monitoring the induction of the expressions of glial fibrillary acidic protein (GFAP) and ionized calcium binding adapter molecule 1 (IBA-1), respectively [80]. This evidence concerns the gene AIF1 and glioblastoma.